Portfolio

What They Do

Invectys

Invectys is a biotechnology company at the forefront of developing novel immunotherapies for cancer treatment. Leveraging cutting-edge research in the field of oncolytic viruses and immunotherapy, Invectys aims to harness the power of the immune system to target and destroy cancer cells. Their innovative approach involves engineering viruses to selectively infect and replicate within tumor cells, triggering an immune response that leads to the elimination of cancerous tissue. By combining the specificity of viral targeting with the potency of the body's own immune defenses, Invectys seeks to provide more effective and personalized treatment options for patients with various types of cancer. With a commitment to advancing scientific understanding and clinical development, Invectys strives to revolutionize cancer therapy and improve outcomes for patients worldwide.